Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spanish regions under pressure to extend breast screening age groups:

This article was originally published in Clinica

Executive Summary

Spain's leading breast cancer awareness and pressure group, FECMA, considers the country's mammography-based screening campaigns to be "excellent", but nevertheless believes that the lower age-limit of the call-up system should be lowered. In statements reporting the high success rates that result from the early detection of most of the 15,000 cases diagnosed annually, FECMA president Maria Antonia Gimon said that while regional authorities were targeting the 50-69-year age group, "it would be ideal for screening to be progressively extended to start at 45 years". A spokesperson for the federation (Federacion Espanola de Cancer de Mama) told Clinica that some regional authorities (screening policies are among the areas of healthcare that have been decentralised) are reportedly considering its recommendations.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052396

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel